BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ASCH - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://asch.net
X-WR-CALDESC:Events for ASCH
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260911
DTEND;VALUE=DATE:20260913
DTSTAMP:20260403T220447
CREATED:20260401T191946Z
LAST-MODIFIED:20260401T191946Z
UID:3326-1789084800-1789257599@asch.net
SUMMARY:Curious Minds: Psychedelic Therapy Meets Clinical Hypnosis (NTSCH)
DESCRIPTION:Organization: North Texas Society of Clinical Hypnosis  \nWebsite: https://northtexashypnosis.org/   \nEvent Title: Curious Minds: Psychedelic Therapy Meets Clinical Hypnosis   \nAdvanced Workshop  \nAgenda:  Agenda \nDates: 09/11/2026 & 09/12/2026  \nLocation: Hybrid  \nCE: 16  \nContact : Tracy Payton Watson\, LPC tracypaytonwatson@gmail.com  \nDescription: This workshop is intended for health professionals who want to learn about the emerging field of psychedelic-assisted therapy (PAT) and how hypnosis can support individuals in this context. Participants will gain an understanding of the primary agents used in PAT\, their neurobiological effects\, therapeutic indications\, and a typical protocol for preparation\, dosing\, and integration. The session will address ethical and legal considerations\, clinical risks\, and principles of harm reduction.  \nA central focus is the application of clinical hypnosis to assist clients during the preparation and integration phases of psychedelic experiences. Through a blend of presentations\, group discussions\, and experiential exercises\, attendees will explore hypnotic principles and interventions that clarify intention\, facilitate navigation of expanded states\, and promote integration of insights. The workshop will highlight how hypnosis can evoke transformative and “mystical” experiences and support emotional and behavioral change\, all grounded in the latest neuroscience and clinical research. Join us to deepen your understanding of this emerging field and expand your therapeutic skills for working with clients interested in or undergoing psychedelic-assisted therapy.  \nLearning Objectives:   \n1.  Advanced Workshop Introduction and Overview: Exploring the intersection between psychedelic assisted therapy and clinical hypnosis  \nAt the conclusion of this session\, the participant will be able to: Describe two similarities between hypnotic and psychedelic states \n2. Brief history of psychedelic use \nAt the conclusion of this session\, the participant will be able to:  \n\nDescribe the historical development of psychedelic therapies from indigenous traditions to contemporary clinical research \nIdentify two major milestones in the modern resurgence of psychedelic research\nIdentify two potential clinical applications of combining hypnosis with psychedelic therapy\n\n3. Introduction to psychedelics \nAt the conclusion of this session\, the participant will be able to:  \n\nIdentify four commonly studied psychedelic or psychedelic-adjacent compounds used in therapeutic settings \nDescribe at least one therapeutic mechanism associated with one compound discussed\n\n4. Psychedelics and clinical hypnosis: Neurobiology and neuroplasticity \nAt the conclusion of this session\, the participant will be able to:  \n\nDescribe two neurobiological mechanisms associated with psychedelic states \nExplain how neuroplasticity contributes to therapeutic change in psychedelic-assisted therapy \nIdentify two similarities between hypnotic and psychedelic shifts in attention and perception\n\n\n Psychedelics and therapeutic applications\n\nAt the conclusion of this session\, the participant will be able to:  \n\nIdentify four mental health conditions currently studied in psychedelic-assisted therapy \nDescribe how hypnosis complements psychedelic-assisted treatment for at least one of the conditions discussed \n\n\n Psychedelics\, clinical hypnosis\, and trauma therapy\n\nAt the conclusion of this session\, the participant will be able to:  \n\nDescribe two potential benefits of psychedelic-assisted therapy for trauma treatment \nIdentify one way clinical hypnosis can support trauma processing before or after a psychedelic session \n\n\n Mystical experiences\n\nAt the conclusion of this session\, the participant will be able to:  \n\nDescribe mystical experience as described in psychedelic research literature \nIdentify two therapeutic implications of mystical-type experiences \n\n\n Mystical Experience Experiential and wrap up\n\nAt the conclusion of this session\, the participant will be able to:  \n\nObserve the use of hypnotic techniques to facilitate altered states of awareness \n\n\n Common therapeutic models in psychedelic assisted therapy\n\nAt the conclusion of this session\, the participant will be able to:  \n\nIdentify three therapeutic models used in psychedelic-assisted therapy \nDescribe how one of these models aligns with hypnotherapeutic approaches \n\n\n Overview – Stages of psychedelic assisted therapy\n\nAt the conclusion of this session\, the participant will be able to:  \n\nList four stages of psychedelic-assisted therapy \nDescribe the clinical purpose of each stage \n\n\n Hypnotic techniques for preparation and session facilitation\n\nAt the conclusion of this session\, the participant will be able to:  \n\nDescribe two strategies for psychological preparation prior to psychedelic sessions \nIdentify one hypnotic technique to facilitate/support safety \nDescribe and apply two hypnotic strategies for affect regulation \n\n\n Hypnotic techniques for integration\n\nAt the conclusion of this session\, the participant will be able to:  \n\nDescribe two goals of integration following psychedelic experiences \nIdentify two hypnotic strategies to support post-session meaning-making and integration \n\n\n Ethics and Clinical Considerations\n\nAt the conclusion of this session\, the participant will be able to:  \n\nIdentify two ethical considerations relevant to psychedelic-assisted therapy \nIdentify two safety considerations for psychedelic-assisted therapy \nHave any questions about the workshop answered \n\nSpeaker info:  \nCiara Christensen\, PhD  – Ciara_C_2025_CV
URL:https://asch.net/event/curious-minds-psychedelic-therapy-meets-clinical-hypnosis-ntsch/
LOCATION:Hybrid
CATEGORIES:Component-Sponsored CE
END:VEVENT
END:VCALENDAR